NCT04851483View on ClinicalTrials.gov

A Trial to Learn What Happens to Different Medicinal Forms of BAY2328065 When They Enter the Body and How Safe They Are in Healthy Male and Female Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

April 28, 2021

Primary Completion Date

December 14, 2021

Study Completion Date

February 14, 2022

Conditions
Endometriosis
Interventions
DRUG

BAY2328065

Solid Form, Oral administration.

DRUG

Placebo

Matching placebo of BAY2328065.

Trial Locations (1)

68167

CRS Clinical-Research-Services Mannheim GmbH, Mannheim

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT04851483 - A Trial to Learn What Happens to Different Medicinal Forms of BAY2328065 When They Enter the Body and How Safe They Are in Healthy Male and Female Participants | Biotech Hunter | Biotech Hunter